BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15301422)

  • 1. Diagnostic, endocrinological, behavioral, and DNA ploidy differences between squamous cell and adenomatous carcinoma of the cervix uteri.
    Lindström AK; Hellberg D; Bäckström T; Stendahl U
    Oncol Res; 2004; 14(7-8):321-4. PubMed ID: 15301422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA aneuploidy in invasive carcinoma of the uterine cervix.
    Kashyap V; Bhambhani S
    Indian J Pathol Microbiol; 2000 Jul; 43(3):265-9. PubMed ID: 11218670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No prognostic impact of flow-cytometric measured DNA ploidy and S-phase fraction in cancer of the uterine cervix: a prospective study of 465 patients.
    Kristensen GB; Kaern J; Abeler VM; Hagmar B; Tropé CG; Pettersen EO
    Gynecol Oncol; 1995 Apr; 57(1):79-85. PubMed ID: 7705705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlations between serum progesterone and smoking, and the growth fraction of cervical squamous cell carcinoma.
    Lindström A; Backström T; Hellberg D; Tribukait B; Strang P; Stendahl U
    Anticancer Res; 2000; 20(5C):3637-40. PubMed ID: 11268431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Flow cytometric evaluation of DNA ploidy pattern in uterine cancer].
    Watanabe T; Izumi S; Yamaoka K; Tsutsui F; Nozawa S
    Nihon Rinsho; 1992 Oct; 50(10):2432-8. PubMed ID: 1447814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytologic charcteristics of histologic forms of cancer of the uterine cervix].
    Botnar' ER
    Arkh Patol; 1977; 39(3):56-63. PubMed ID: 871256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric analysis of DNA ploidy and S-phase fraction of Stage IIIB cervical carcinoma.
    Wilailak S; Rochanawutanon M; Srisupundit S; Aumkhyan A; Pattanapanyasat K
    Eur J Gynaecol Oncol; 2004; 25(4):428-30. PubMed ID: 15285296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric evaluation of early invasive cervical cancer.
    Connor JP; Miller DS; Bauer KD; Murad TM; Rademaker AW; Lurain JR
    Obstet Gynecol; 1993 Mar; 81(3):367-71. PubMed ID: 8437788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of S-phase fraction as measured by DNA flow cytometry in gynecologic malignancies.
    Strang P; Stendahl U; Tribukait B
    Ann N Y Acad Sci; 1993 Mar; 677():354-63. PubMed ID: 8494220
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cervix uteri cancer: determination of DNA content by means of cytophotometry].
    Wistuba I; Roa I; Villaseca MA; Araya JC; Capurro I
    Rev Med Chil; 1993 Aug; 121(8):873-9. PubMed ID: 8296094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA content in cervical carcinoma: a flow cytometric assessment of DNA heterogeneity.
    Chang AR; Grignon DJ; Keeney MM; Koster JL; Kirk ME
    Int J Gynecol Pathol; 1994 Oct; 13(4):330-6. PubMed ID: 7814194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Squamous and adenocarcinoma of the uterine cervix: a comparison using routine data.
    Silcocks PB; Thornton-Jones H; Murphy M
    Br J Cancer; 1987 Mar; 55(3):321-5. PubMed ID: 3567065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of ploidy level in human tumors. I. Carcinoma of the uterus.
    Atkin NB
    J Natl Cancer Inst; 1976 May; 56(5):909-10. PubMed ID: 994202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diffusion weighted imaging features of normal uterine cervix and cervical carcinoma].
    Zhang Y; Liang BL; Gao L; Ye RX; Shen J; Zhong JL
    Ai Zheng; 2007 May; 26(5):508-12. PubMed ID: 17672942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of epithelial-specific antigen for cytological diagnosis of glandular lesions in the uterine cervix.
    Matsui N; Kajiwara H; Morishita A; Iida T; Nakazawa K; Miyazawa M; Mikami M; Ogawa T; Nakamura N; Sato S
    Pathol Int; 2016 May; 66(5):305-8. PubMed ID: 26792568
    [No Abstract]   [Full Text] [Related]  

  • 16. Prospective analysis of DNA ploidy, proliferative index and epidermal growth factor receptor as prognostic factors for pretreated uterine cancer.
    Nagai N; Oshita T; Fujii T; Kioka H; Katsube Y; Ohama K
    Oncol Rep; 2000; 7(3):551-9. PubMed ID: 10767367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic significance of hyperploid cells in squamous carcinoma of the uterine cervix treated with radiotherapy.
    Court JB; Salman SK; Kerby IJ
    Radiother Oncol; 1994 Dec; 33(3):266-8. PubMed ID: 7716268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting response to treatment in human cancers of the uterine cervix: sequential biopsies during external beam radiotherapy.
    Durand RE; Aquino-Parsons C
    Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):555-60. PubMed ID: 14751527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of prognostic factors following flow-cytometric DNA analysis after cytokeratin labelling: II. Cervical and endometrial cancer.
    Wimberger P; Hillemanns P; Kapsner T; Hepp H; Kimmig R
    Anal Cell Pathol; 2002; 24(4-5):147-58. PubMed ID: 12590151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Squamous cell carcinoma of the cervix: HPV 16 and DNA ploidy as predictors of survival.
    Jarrell MA; Heintz N; Howard P; Collins C; Badger G; Belinson J; Nason F
    Gynecol Oncol; 1992 Sep; 46(3):361-6. PubMed ID: 1326474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.